Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuping Sun

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
BMC Plant Biology|May 21, 2024
GhVIM28, a negative regulator identified from VIM family genes, positively responds to salt stress in cottonZhining Yang, Xuke Lu, Ning Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I StudyMinjiang Chen, Iurie Bulat, Marina Maglakelidze, et al.
Journal of the American Chemical Society|March 18, 2024
Superconductivity and Charge-Density-Wave-Like Transition in Th<sub>2</sub>Cu<sub>4</sub>As<sub>5</sub>Shaohua Liu, Qingchen Duan, Baizhuo Li, et al.
BMC Plant Biology|February 19, 2025
GhADT5 enhances alkali stress tolerance in cotton by regulating phenylalanine-derived flavonoid biosynthesis and antioxidant defenseLidong Wang, Hongyu Nan, Menghao Zhang, et al.
The Lancet. Oncology|February 28, 2025
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm studyZiming Li, Yan Wang, Yuping Sun, et al.
Cancer Cell|March 6, 2026
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trialJianchun Duan, Yuping Sun, Qiming Wang, et al.
Bioactive Materials|January 6, 2025
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacologyJing Lu, Ying Zhang, Chunyan Yan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 23, 2016
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]Binghe Xu, Fuguo Tian, Jingrui Yu, et al.
Cancer Communications (London, England)|October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II studyZhi Peng, Tianshu Liu, Jia Wei, et al.
BMC Medicine|May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV studyJin Li, Shukui Qin, Lu Wen, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
BMC Plant Biology|May 21, 2024
GhVIM28, a negative regulator identified from VIM family genes, positively responds to salt stress in cottonZhining Yang, Xuke Lu, Ning Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I StudyMinjiang Chen, Iurie Bulat, Marina Maglakelidze, et al.
Journal of the American Chemical Society|March 18, 2024
Superconductivity and Charge-Density-Wave-Like Transition in Th<sub>2</sub>Cu<sub>4</sub>As<sub>5</sub>Shaohua Liu, Qingchen Duan, Baizhuo Li, et al.
BMC Plant Biology|February 19, 2025
GhADT5 enhances alkali stress tolerance in cotton by regulating phenylalanine-derived flavonoid biosynthesis and antioxidant defenseLidong Wang, Hongyu Nan, Menghao Zhang, et al.
The Lancet. Oncology|February 28, 2025
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm studyZiming Li, Yan Wang, Yuping Sun, et al.
Cancer Cell|March 6, 2026
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trialJianchun Duan, Yuping Sun, Qiming Wang, et al.
Bioactive Materials|January 6, 2025
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacologyJing Lu, Ying Zhang, Chunyan Yan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 23, 2016
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]Binghe Xu, Fuguo Tian, Jingrui Yu, et al.
Cancer Communications (London, England)|October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II studyZhi Peng, Tianshu Liu, Jia Wei, et al.
BMC Medicine|May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV studyJin Li, Shukui Qin, Lu Wen, et al.
Pageof 35